Centers for Medicare and Medicaid Services
Limited Preliminary Injunction Issued for CMS Vaccine Mandate
On November 29, 2021, a federal court in Missouri enjoined the Centers for Medicare and Medicaid Services’ (CMS) vaccine mandate in the following states: Alaska, Arkansas, Iowa, Kansas, Missouri, Nebraska, New Hampshire, North Dakota, South Dakota, and Wyoming. Those ten states filed a lawsuit on November 10, 2021, challenging the vaccine mandate and requesting a preliminary injunction. The new CMS vaccine mandate which we wrote about here requires covered staff to receive their first COVID-19 vaccine dose by December 5, 2021 and be fully vaccinated by January 4, 2022. In granting the preliminary injunction, the district court specifically ordered: Defendants are preliminarily enjoined from the implementation and enforcement of 86 Fed. Reg. 61,555 (Nov. 5, 2021), the Interim Final Rule with Comment Period entitled “Medicare and Medicaid Programs; Omnibus COVID-19 Health Care Staff Vaccination,” against any and all Medicare- and Medicaid-certified providers and suppliers within the States of Alaska, Arkansas, Iowa, Kansas, Missouri, Nebraska, New Hampshire, North Dakota, South Dakota, and Wyoming pending a trial on the merits of this action or until further order of this Court. Defendants shall immediately cease all implementation or enforcement of the Interim Final Rule with Comment Period as to any Medicare- and Medicaid certified providers and suppliers within the States of Alaska, Arkansas, Iowa, Kansas, Missouri, Nebraska, New Hampshire, North Dakota, South Dakota, and Wyoming. What this means is that as of November 29, 2021, the December 5, 2021, and January 4, 2022 deadlines are on hold for employers covered by the CMS mandate in Alaska, Arkansas, Iowa, Kansas, Missouri, Nebraska, New Hampshire, North Dakota, South Dakota, and Wyoming. Any vaccine mandates enforced by covered employers in those states will be considered voluntary and subject to any state laws regarding vaccine mandates. Of the ten states, only Arkansas, Iowa, and Kansas have laws regulating COVID-19 vaccine mandates for private employers: Arkansas – On October 13, 2021, Arkansas’ Governor allowed several vaccine-related bills to become law without his signature. The bills require employers to allow employees to obtain a waiver from a COVID-19 vaccine mandate if the employee produces a negative COVID-19 test once a week or provides proof of COVID-19 antibodies once every six months. Iowa – On October 29, 2021, Iowa’s Governor signed a law requiring employers to grant exemptions from vaccine mandates beyond those required by federal law. Specifically, in addition to waivers for sincerely held religious beliefs, Iowa employers that voluntarily implement vaccine mandates must grant a waiver if an employee submits a statement that receiving the vaccine would be injurious to the health and well-being of the employee or an individual residing with the employee. In addition, Iowa employees discharged for not complying with an employer’s vaccine mandate are eligible for unemployment benefits under the new law. Kansas – On November 22, 2021, the Governor of Kansas signed a law with medical waiver requirements similar to Iowa’s law. On religious waivers, Kansas’ law goes beyond what is required by federal law, mandating that employers grant requests for religious exemptions “without inquiring into the sincerity of the request.” The law also outlines a complaint and investigation procedure for alleged violations and provides for monetary penalties that increase depending on the size of the employer. In addition, like the Iowa law, Kansas employees discharged for not complying with an employer’s vaccine mandate are eligible for unemployment benefits. The Biden Administration will almost certainly appeal the preliminary injunction. The Eighth Circuit Court of Appeals would consider the appeal and could overturn the injunction and reinstate the mandate. Given the timeline, we expect that new compliance deadlines would be established in the event the preliminary injunction is overturned. What should employers do? Covered employers in the ten states at issue who do not wish to proceed with a voluntary vaccine mandate may pause their current efforts to comply with the CMS vaccine mandate, but should at a minimum proceed with preparing a policy, religious and medical exemption forms, and an exemption review process so that employers are ready to proceed within any established deadlines if the preliminary injunction is lifted and the mandate is reinstated. This is the same recommendation we have given to large employers covered by the Occupational Safety and Health Administration’s COVID-19 Vaccination and Testing Emergency Temporary Standard (OSHA ETS), which was stayed by the Fifth Circuit Court of Appeals on November 12, 2021.[1] Employers looking for consistency when it comes to COVID-19 vaccine mandates will not find it in today’s ruling and healthcare employers can once again add themselves to the list of employers who operate in multiple states and must undertake the task of wading through the various federal mandates and their legal statuses. It is both possible and probable that multi-state healthcare employers will be required to comply with CMS’s federal vaccine mandate in one state while operating in another state wherein, at least for now, CMS’s federal vaccine mandate no longer exists. Dorsey’s employment and health care attorneys will continue to monitor the developments in this matter and will update our blog with changes. [1] On November 23, 2021, the Biden Administration asked the Sixth Circuit Court of Appeals to reinstate the OSHA ETS vaccine mandate, following a lottery that assigned to that Circuit multiple challenges to the vaccine mandate.
November 29, 2021
by Alissa Smith and Katie Ervin Carlson
Centers for Medicare and Medicaid Services
CMS Advisory Opinion Approves Parent and Wholly-Owned Subsidiary Qualifying as “Single Legal Entity” under the Stark “Group Practice” Definition
The Centers for Medicare & Medicaid Services (“CMS”) released Advisory Opinion No. CMS-AO-2021-01 in June 2021, which gave the requestor the green light to provide designated health services (“DHS”) through wholly-owned subsidiaries while the parent and subsidiaries could qualify as a “single legal entity” under the “group practice” definition of the federal physician self-referral law (or “Stark Law”). As a result, the requestor is eligible for the in-office ancillary services (“IOAS”) exception to the Stark Law. This opinion is notable because CMS issues advisory opinions infrequently and, particularly given recent changes to the CMS advisory opinion regulations (as we wrote about here), other entities may use this opinion as guidance in forming similar arrangements. As background, under the IOAS exception, a physician practice may make referrals for DHS within the practice, but only if it qualifies as a group practice. The term “group practice,” defined in the Stark regulations, requires, among other things, that the practice is a “single legal entity” that operates “primarily for the purpose of being a physician group practice.” Accordingly, a “single legal entity” does not include physicians who are only informally affiliated for the purpose of sharing profits from referrals, but a single legal entity may itself own subsidiary entities. The recent advisory opinion focuses on whether a physician practice with wholly-owned subsidiary physician practices qualifies as a “single legal entity” for the purposes of the IOAS exception. The Advisory Opinion In short, the advisory opinion allows for a group practice with wholly-owned subsidiaries to provide services through those subsidiaries, even if the subsidiaries do not themselves qualify as group practice. The group practice and the subsidiaries, for purposes of the IOAS exception, qualify as a single legal entity. The Arrangement The requestor (“Group Practice”), was the sole owner of two subsidiary physician practices (the “Subsidiaries”). Group Practice was looking to provide services, including DHS, to patients, both directly and through the Subsidiaries. Group Practice attested that, while the Subsidiaries would retain their own Medicare enrollment and use billing numbers assigned to them to bill Medicare for items and services they furnish to beneficiaries, the material assets and business functions of the Subsidiaries would be transferred to Group Practice or the practice’s management company. The management company would provide non-clinical services to both Group Practice and the Subsidiaries. The revenue and expenses of the Subsidiaries would be attributed to Group Practice. Furthermore, the clinical employees and contractors of the Subsidiaries would become employees and contractors of Group Practice, and the patients served by the Subsidiaries would be considered patients of Group Practice. Group Practice certified that it met all requirements of a group practice itself and that the arrangement with the Subsidiaries would meet all other requirements of a group practice, such as having centralized decision-making. The Subsidiaries did not qualify as group practices on their own, and Group Practice specifically sought to determine if it, in its arrangement with the Subsidiaries, could qualify as a “single legal entity” for the purposes of the group practice definition, thus meeting this requirement of the IOAS exception. CMS Analysis CMS found that Group Practice and the Subsidiaries would qualify as a single legal entity. In concluding this, CMS focused heavily on two aspects of the relationship: (1) the revenue and expenses of the Subsidiaries would be attributed to Group Practice, and (2) the clinical employees and contractors of the Subsidiaries would become employees and contractors of Group Practice. CMS found the first factor to be adequate even though the Subsidiaries maintained their own Medicare enrollments and payor contracts separate from Group Practice. What This Means for Physician Practices Reliance on Advisory Opinions On January 1, 2020, the Stark regulations regarding advisory opinions were revised. Prior to this revision, only the entity requesting the advisory opinion and others who were parties to the specific arrangement could rely on the opinion. Under the revised advisory opinion regulations, the Secretary of HHS will not pursue sanctions against other entities who did not make the request for the opinion and who are not parties to the specific arrangement, as long as their arrangement is ”indistinguishable in all its material aspects” from an arrangement which received a favorable advisory opinion from CMS. See our detailed analysis of the revised advisory opinion regulations here. This means that other physician practices outside of Group Practice and the Subsidiaries can make referrals to wholly-owned subsidiaries if such arrangements are indistinguishable in all material aspects from the one described in the opinion and otherwise meet the requirements of the group practice definition and IOAS exception. Below is a brief list and description of factors that would likely be considered material to this arrangement, and thus necessary for physician practices seeking to rely on Advisory Opinion No. CMS-AO-2021-01. Referrals to Subsidiaries Parent-Subsidiary Relationship The parent-subsidiary relationship is a key factor in the “single legal entity” analysis. As stated above, physicians that are only informally affiliated do not qualify as a group practice. Further, the advisory opinion expressly states that Group Practice and the Subsidiaries qualify as a single legal entity “provided that [Group Practice] is the sole owner of the Subsidiaries.” However, it is not necessary for the subsidiary physician practice itself to qualify as a group practice. Below are two diagrams: Diagram 1 illustrates affiliated entities that do not qualify as a group practice, and Diagram 2 illustrates the parent-subsidiary relationship that CMS deemed appropriate in the advisory opinion. Revenue and Expenses Attributed to Parent Given the emphasis CMS put on the framework of Group Practice and the Subsidiaries’ revenue and expenses, this element would likely be considered material. Therefore, subsidiary revenue and expenses should be attributed to the group practice if the entities are looking to qualify as a single legal entity. However, as mentioned above, it is not necessary for a subsidiary physician practice to bill Medicare under the parent. A subsidiary may have its own Medicare number and bill separately from the parent, as long as the revenue and expenses of the subsidiary are ultimately attributed to the parent. Employees and Contractors are Those of the Parent Similarly, if a subsidiary’s employees and/or contractors are not considered to be the employees and/or contractors of the group practice, it is unlikely that the arrangement would fall within the exception, because this, too, was a focus of the opinion and thus is likely material from CMS’s point of view. Conclusion Following issuance of Advisory Opinion No. CMS-AO-2021-01 and recent regulatory changes regarding reliance on advisory opinions, parent physician practices may make referrals for DHS to wholly-owned subsidiary practices as a single legal entity if all other elements of the group practice definition and IOAS exception are met. This advisory opinion only addresses the definition of a single legal entity. Entities must ensure that the other elements of the group practice definition and IOAS exception to the Stark Law are also met if they choose to form a parent/subsidiary referral relationship. Please contact the authors or your regular Dorsey attorney with any questions. Summer Associate Hannah McCallum provided substantial assistance in the drafting of this article.
August 30, 2021
by Laura B. Morgan
Centers for Medicare and Medicaid Services
Living in a Virtual World: The Post-Pandemic Future of Telehealth
The COVID-19 pandemic required health care providers of all sizes to make drastic changes to the mode of patient care delivery. Telehealth quickly emerged as a safe alternative to in-person patient visits, and many providers quickly transitioned to virtual services. The pandemic-initiated expansion of telehealth was rapid and significant, but the pandemic likely accelerated existing trends more than creating new ones. The increased availability of telehealth has offered patients greater access levels and types of care that would otherwise be difficult to obtain due to geography, limited appointment availability, or affordability. Despite the increased access to care and positive experiences with telehealth over the past year and a half, many regulatory actions temporarily enabling the use of telehealth services have expired or will end in the coming months. What does the post-COVID future hold for tele health? Health care industry leaders are tracking the following developments: Licensing State professional licensure laws are major obstacles for telehealth providers wanting to offer telehealth services as an option for patients who reside or are otherwise located in other states. State laws governing the practice of medicine, nursing, social work, and other health professions generally require the provider furnishing care to be licensed in the state where the patient is located. At the beginning of the pandemic, the spike in demand for virtual care led states to quickly take action to loosen or waive professional licensure requirements. Many states allowed out-of-state health care providers of all types to provide telehealth services to their residents, including Hawaii, Idaho, and Vermont. States such as Illinois and Maryland permitted telehealth practice only where a provider had a pre-existing relationship with the patient, and others only relaxed requirements for physicians or mental health providers, such as in Minnesota. Post-pandemic, we expect to see continued efforts to remove licensing barriers faced by telehealth providers. Several states have enacted the Interstate Medical Licensure Compact or have entered into cross-border licensure waiver agreements with neighboring states, but these waiver agreements may only apply to certain practitioners or involve slow, costly application processes. Some states may follow the approach taken in Florida and Georgia, where health care providers can obtain a “telemedicine license” with less burdensome requirements. Action on the federal level is also possible. In response to COVID-19, the Centers for Medicare & Medicaid Services (“CMS”) temporarily waived the Medicare requirement that providers be licensed in the state they are delivering telemedicine services when practicing across state lines, subject to certain conditions. While this waiver does not exempt providers from licensure requirements under state law, subsequent action taken at the federal level may set a trend followed by state governments. Providers should also be aware of existing state laws permitting the practice of telehealth across state lines when an existing patient is on vacation or attending college in another state. For example, in Minnesota, out-of-state physicians are exempt from licensure requirements if only providing telehealth services on an “irregular or infrequent basis” as defined in Minn. Stat. § 147.032. And Colorado allows non-Colorado-licensed health care providers to provide occasional services or consultation via telehealth to patients in Colorado as long as they meet certain requirements, such as maintaining certain levels of insurance, not maintaining an office in the state, and not informally or formally agreeing to provide care on a regular or routine basis. See Colo. Rev. Stat. § 12-240-107. Reimbursement Before the pandemic, reimbursement options for telehealth were limited and low payment rates were a significant financial burden for providers seeking to provide telehealth services. As we described in a previous blog post, CMS implemented sweeping changes to Medicare reimbursement and coverage requirements at the start of the COVID-19 outbreak. Dozens of new services were added to the list of telehealth services covered by Medicare, restrictions on geography and originating sites were removed, and payment rates for telehealth services were raised to match the rates for the same in-person service. On July 13, CMS released its annual proposed rule for payments under the Medicare Physician Fee Schedule, which would make many temporary Medicare flexibilities for mental and behavioral health services permanent. If finalized, the rule would allow beneficiaries to receive such telehealth services from home, reimburse providers for audio-only services, and keep certain recently added services on the Medicare telehealth list through December 31, 2023. The rule would require an in-person visit within six months prior to an initial telehealth service and at least once every six months thereafter, but CMS is seeking input on whether a different interval may be necessary or appropriate. The agency is also soliciting comment on: Whether additional documentation should be required in the patient’s medical record to support the clinical appropriateness of audio-only telehealth; Whether or not audio-only telehealth for particular high-level services should be covered; and What additional guardrails should be put in place in order to minimize concerns about program integrity and patient safety. Several states have passed or proposed payment parity legislation that would permanently require insurance coverage and/or reimbursement for certain telehealth services at a level equal to in-person visits. For example, legislation was recently enacted in Oklahoma requiring payment parity for all telemedicine services. In states like Georgia and California, laws require equal coverage for both virtual and in-person services, but allow payers and providers to negotiate alternate payment rates. A recent Connecticut law requires payment parity for telehealth services under its state Medicaid program, and a Massachusetts law mandates payment parity for behavioral health services. Privacy In response to the pandemic, the Office for Civil Rights (“OCR”) announced several telehealth flexibilities to allow providers to care for patients remotely during the pandemic. OCR announced it would not impose penalties on providers for noncompliance with certain HIPAA obligations in connection with their “good faith provision of telehealth” using any non-public communication platform, such as FaceTime or Zoom. Given increasing concerns about cybersecurity and privacy risks, we expect continued discussions at the federal and state level about how to safeguard patient’s health information while allowing continued access to telehealth services. Providers should conduct a comprehensive risk assessment of its privacy and security protections and vendor agreements to ensure all telehealth technologies and IT systems comply with HIPAA standards. Conclusion The COVID-19 pandemic has profoundly changed the health care delivery landscape. As emergency orders end and regulatory flexibilities expire, policymakers at the state and national level are considering how best to regulate telehealth post-pandemic. Telehealth services ease the burden of obtaining quality healthcare services for medically underserved populations, including communities of color, people with disabilities, and residents of rural areas. Telehealth also gives patients the opportunity to conveniently obtain routine and preventative care, which could positively impact health outcomes and improve health equity. Dorsey attorneys are closely monitoring federal and state actions regarding telehealth. For more information on how to navigate the existing legal landscape and prepare for future developments, contact the authors or your regular Dorsey attorney.
July 28, 2021
by Jamie McCarty and Charis Zimmick
Centers for Medicare and Medicaid Services
Nursing Facilities and CMPs: The Latest Fight
On January 18, 2021, a lawsuit was filed against the U.S. Department of Health and Human Services (“HHS”) and the Centers for Medicare and Medicaid Services (“CMS”) challenging a CMS policy change dating back to 2017. The plaintiffs, the National Consumer Voice for Quality Long-Term Care and the California Advocates for Nursing Home Reform, are non-profit consumer advocacy groups for long-term care. The policy at the heart of the lawsuit concerns a change CMS made as to how civil monetary penalties (“CMP”) are imposed against nursing facilities. As a bit of background, under the Nursing Home Reform Act of 1987 (NHRA), Congress created a scheme whereby CMS and the states shared responsibility for ensuring states meet federal quality and safety standards of resident care for residents in nursing facilities. Under this scheme, state agencies regularly evaluate a nursing facility’s compliance with the requirements by conducting periodic surveys, often unannounced. The survey findings would then be reported to the CMS regional offices (“RO”) with recommended enforcement actions. Acting on the survey results and the recommendation from the state agency, the ROs would then impose per-day CMPs on facilities for past noncompliance with federal standards. The 2017 change, however, made clear that ROs, regardless of findings and recommendations from state survey agencies, are to impose a CMP for past noncompliance based only on each instance of noncompliance that occurred but was corrected before the state survey is conducted. “Past noncompliance” is a statutorily defined term which means those situations in which a state finds that a nursing facility meets all of the federal requirements “but, as of a previous period, did not meet such requirements.” With this 2017 policy change, if a facility has corrected that noncompliance just before the survey team shows up at the facility, even if the noncompliance had lasted months, then the facility would not be penalized for each day of noncompliance but rather, would receive a “per instance” CMP. The plaintiffs in the recently filed litigation argue that, by announcing to the state survey agencies that its ROs will assess CMPs only for each instance of past noncompliance and not for each day of past noncompliance, CMS’ policy change effectively contravenes Congress’ express intent to give the states the direction to recommend (and CMS the discretion to impose) a per-day CMP for past noncompliance. The complaint alleges that the plaintiffs have been adversely impacted by this change. Per instance CMPs currently range in amount, as adjusted for inflation, from a minimum of $2,233 to a maximum of $22,320 for each instance of noncompliance. 42 C.F.R. § 488.438(a)(2); 45 C.F.R. § 102.3. Taking the example of a non-immediate jeopardy deficiency, the maximum per-instance CMP that a nursing facility faces for this type of deficiency is $22,320, regardless of whether the facility has allowed the deficiency to remain uncorrected for one day, one week, or one month. By contrast, the maximum per day CMP for this type of deficiency begins to exceed, and quickly dwarfs, the maximum per instance CMP whenever the facility has allowed the deficiency to remain uncorrected for four or more days (4 x $6,695 = $26,780). The plaintiffs argue that the imposition of only per instance CMPs for past noncompliance will thus encourage nursing facilities to knowingly allow deficiencies to linger for days, weeks, or even months, until the next state survey, because the penalty will be the same regardless of whether the deficiency persisted for a day or a month. As long the facility remedies the deficiency before the next survey (usually 12-15 months apart), the facility can only be fined the per instance maximum of $22,320. The human impact of this, as argued in the lawsuit, is that for each day a facility permits a deficiency to persist, whether it be for one week or a number of months, the residents at that facility may be endangered by the deficiency. As a result, the plaintiffs assert that if facilities do not fear the monetary penalties, they will be less inclined to make their facilities safe for residents. Certainly, nursing facilities across the country will see it very differently from the plaintiffs in the litigation. Because surveys are unannounced, facilities do not “let down their guard” and intentionally allow the facilities to become less safe simply because they know they will be assessed a per instance penalty instead of a per day penalty. Rather, the possibility of getting a per instance CMP (as opposed to a per day penalty) would be an incentive for nursing facilities to identify and correct issues immediately so that such issues will be identified as past noncompliance when the state survey agency does come knocking. While there may be some bad actors out there, most nursing facilities are doing all that they can to avoid noncompliance. In other words, facilities’ actions and decisions are not based upon whether they would rather have a per day versus a per instance penalty. It is also notable that, while the litigation mentions the COVID-19 pandemic, it does not mention the enhanced CMPs that are now available for infection control violations. CMS has been aggressively using these enhanced CMPs to impose large per instance and large per day CMPs for relatively low-level transgressions. For example, having one employee make an error on his/her mask wearing or daily documentation regarding COVID-19 symptoms (even if it does not lead to any adverse consequences) can result in a $15,000 CMP if the facility had any infection control deficiency in the last two years. A surveyor may see a staff member not following the requirements every time (e.g. not wiping down the face shield after they sit it down for a few seconds, letting their mask fall below their nose, etc.) and may assess severe penalties as a result. While most facilities would agree that infection control is important, these penalties are excessive, especially taking into account they are assessed for some of the more minor and isolated events that may occur. Facilities should be cognizant of this litigation and the views expressed by the organizations seeking to change the CMP landscape to be harsher than it is now. CMS has already shown its willingness to increase the CMP levels for infection control purposes, and they may seek to expand such penalties on a more permanent basis. If you have any questions about any of the topics addressed in this post, please contact the authors or any member of the Dorsey & Whitney Health Transactions & Regulations Practice Group.
February 10, 2021
by Katie Cownie, Rebecca A. Brommel, and Carson Lamb